Norovirus Disease in Older Adults Living in Long-Term Care Facilities: Strategies for Management
- 124 Downloads
Purpose of Review
Noroviruses are the most common cause of gastroenteritis outbreaks in long-term care facility (LTCFs). This review summarizes the most up-to-date knowledge on norovirus infection in LTCFs with the aim of identifying potential strategies for management.
LTCF residents are at greater risk of norovirus infection. Early identification of norovirus infection and prompt initiation of appropriate supportive therapy are required to reduce morbidity and mortality. Measures to prevent outbreaks and reduce the risk of norovirus infection in LTCFs include timely diagnosis and implementation of infection control interventions to limit virus transmission.
Current guidelines for prevention and control are based on generic principles of infection control. Real-time reverse transcription-quantitative polymerase chain reaction assays have been the gold standard for the rapid and sensitive detection of noroviruses. With the recent breakthroughs of human norovirus in vitro culture, doors are now opened to evaluate the efficacy of environmental disinfectants and hand hygiene options. Additionally, development of licensed vaccines against noroviruses may provide another important tool for infection prevention among high-risk individuals.
KeywordsNorovirus Older adults Long-term care facilities Management
Compliance with Ethical Standards
Conflict of Interest
Yingxi Chen, Aron Hall and Martyn Kirk declare no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Human and Animal Rights
All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.•• Kirk MD, Pires SM, Black RE, Caipo M, Crump JA, Devleesschauwer B, et al. World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis. PLoS Med. 2015;12:e1001921. Most recent estimates of the global burden of 22 foodborne bacterial, protozoal, and viral infections. CrossRefPubMedPubMedCentralGoogle Scholar
- 2.•• Ahmed SM, Hall AJ, Robinson AE, Verhoef L, Premkumar P, Parashar UD, et al. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14:725–30. Reviews the global prevalence of norovirus gastroenteritis. CrossRefPubMedGoogle Scholar
- 6.• Hall AJ, Wikswo ME, Manikonda K, Roberts VA, Yoder JS, Gould LH. Acute gastroenteritis surveillance through the National Outbreak Reporting System, United States. Emerg Infect Dis. 2013;19:1305–9. Demonstrates a more complete characterization of acute gastroenteritis outbreaks, particularly the relative importance of specific transmission modes and settings for norovirus. CrossRefPubMedPubMedCentralGoogle Scholar
- 18.• Trivedi TK, Desai R, Hall AJ, Patel M, Parashar UD, Lopman BA. Clinical characteristics of norovirus-associated deaths: a systematic literature review. Am J Infect Control. 2013;41:654–7. Reviews of clinical and epidemiologic characteristics of deaths assocaited with norovirus infection. CrossRefPubMedGoogle Scholar
- 22.Kroneman A, Verhoef L, Harris J, Vennema H, Duizer E, van Duynhoven Y, et al. Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the foodborne viruses in Europe network from 1 July 2001 to 30 June 2006. J Clin Microbiol. 2008;46:2959–65.CrossRefPubMedPubMedCentralGoogle Scholar
- 31.•• Costantini VP, Cooper EM, Hardaker HL, Lee LE, Bierhoff M, Biggs C, et al. Epidemiologic, virologic, and host genetic factors of norovirus outbreaks in long-term care facilities. Clin Infect Dis. 2016;62:1–10. Demostrates the epidemiology, virology, and genetic host factors of naturally occurring norovirus outbreaks in LTCF. CrossRefPubMedGoogle Scholar
- 41.•• de Graaf M, van Beek J, Koopmans MP. Human norovirus transmission and evolution in a changing world. Nat Rev Microbiol. 2016;14:421–33. Most recent review describing the transmission, pathogenesis and evolution of human noroviruses, and considering the ongoing risk of norovirus outbreaks, along with the future prospects for treatment. CrossRefPubMedGoogle Scholar
- 44.Hasing ME, Lee BE, Preiksaitis JK, Tellier R, Honish L, Senthilselvan A, et al. Emergence of a new norovirus GII.4 variant and changes in the historical biennial pattern of norovirus outbreak activity in Alberta, Canada, from 2008 to 2013. J Clin Microbiol. 2013;51:2204–11.CrossRefPubMedPubMedCentralGoogle Scholar
- 51.Wilhelmi de Cal I, Revilla A, del Alamo JM, Roman E, Moreno S, Sanchez-Fauquier A. Evaluation of two commercial enzyme immunoassays for the detection of norovirus in faecal samples from hospitalised children with sporadic acute gastroenteritis. Clin Microbiol Infect. 2007;13:341–3.CrossRefPubMedGoogle Scholar
- 52.Updated norovirus outbreak management and disease prevention guidelines. MMWR Recomm Rep. 2011;60: 1–18.Google Scholar
- 56.Lindesmith LC, Ferris MT, Mullan CW, Ferreira J, Debbink K, Swanstrom J, et al. Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial. PLoS Med. 2015;12:e1001807.CrossRefPubMedPubMedCentralGoogle Scholar
- 57.Atmar RL, Baehner F, Cramer JP, Song E, Borkowski A, and Mendelman PM. Rapid Responses to Two Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: A Randomized Controlled Trial. J Infect Dis. 2016;In press.Google Scholar
- 58.•• Lopman BA, Steele D, Kirkwood CD, Parashar UD. The vast and varied global burden of norovirus: prospects for prevention and control. PLoS Med. 2016;13:e1001999. Reviews the evidence for the global burden of norovirus and discusses the prospects for norovirus vaccine development. CrossRefPubMedPubMedCentralGoogle Scholar
- 59.• Aliabadi N, Lopman BA, Parashar UD, Hall AJ. Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations. Expert Rev Vaccines. 2015;14:1241–53. Discusses recent data on human norovirus vaccine development and potential targets for implementation. PubMedGoogle Scholar
- 62.Communicable Diseases Network Australia, Guidelines for the public health management of gastroenteritis outbreaks due to norovirus or suspected viral agents in Australia. 2010.Google Scholar
- 63.Party NW. Guidelines for the management of norovirus outbreaks in acute and community health and social care settings. London: Health Protection Agency; 2012.Google Scholar
- 65.Park GW, Sobsey MD. Simultaneous comparison of murine norovirus, feline calicivirus, coliphage MS2, and GII.4 norovirus to evaluate the efficacy of sodium hypochlorite against human norovirus on a fecally soiled stainless steel surface. Foodborne Pathog Dis. 2011;8:1005–10.CrossRefPubMedGoogle Scholar
- 71.• Hall AJ, Wikswo ME, Pringle K, Gould LH, Parashar UD. Vital signs: foodborne norovirus outbreaks - United States, 2009-2012. MMWR Morb Mortal Wkly Rep. 2014;63:491–5. Analysis of surveillance data suggests that food workers were associated with 70% of foodborne norovirus outbreaks reported to the National Outbreak Reporting System in the US. PubMedGoogle Scholar
- 72.Connolly MA, Communicable disease control in emergencies: a field manual. 2005: World Health Organization.Google Scholar